Marco Investment Management’s Eledon Pharmaceuticals ELDN Stock Holding History

Marco Investment Management’s Portfolio ELDN Stock Details ELDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$120K	Hold	30,344	–	–	0.01%	244
2026 Q1	$93.5K	Hold	30,344	–	–	0.01%	231
2025 Q4	$45.8K	Hold	30,344	–	–	﹤0.01%	227
2025 Q3	$78.6K	Hold	30,344	–	–	0.01%	221
2025 Q2	$82.2K	Hold	30,344	–	–	0.01%	218
2025 Q1	$103K	Hold	30,344	–	–	0.01%	211
2024 Q4	$125K	Hold	30,344	–	–	0.01%	220
2024 Q3	$75.6K	Hold	30,344	–	–	0.01%	224
2024 Q2	$80.1K	Buy	30,344 +5,535	+22%	+$13.2K	0.01%	207
2024 Q1	$51.1K	Buy	+24,809	New	+$44.3K	﹤0.01%	207

Other funds holding ELDN

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DCM

Defilade Capital Management Emeryville, California $747M AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCM

Catalio Capital Management New York $532M AUM 171.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Zimmer Partners New York $4.34B AUM 22.78% 1-Year Est. Return

Marco Investment Management's ELDN Position: Q2 2026 in Review

Marco Investment Management held its Eledon Pharmaceuticals (ELDN) position steady in Q2 2026 at 30,344 shares worth $120K. The position accounts for 0.01% of the portfolio, ranked #244.

Marco Investment Management first reported a position in ELDN in Q1 2024 and has held it in 10 quarters since. The position peaked at $125K in Q4 2024. 161 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

Marco Investment Management held 30,344 shares of Eledon Pharmaceuticals worth $120K as of Q2 2026.
Marco Investment Management left its Eledon Pharmaceuticals share count unchanged in Q2 2026.
Eledon Pharmaceuticals made up 0.01% of Marco Investment Management's portfolio in Q2 2026, its #244 holding.
Marco Investment Management first reported a position in Eledon Pharmaceuticals in Q1 2024 and has held it in 10 quarters since.
Marco Investment Management's Eledon Pharmaceuticals position peaked at $125K in Q4 2024.
161 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Marco Investment Management's 13F filing for Q2 2026, filed 3 Aug 2026.